Nature Communications · 2012 · 146 citations · 47 references
Life SciencesBiologyImmunologyHost-pathogen InteractionsMolecular VirologyVirologyGlycan StructureGlycan-protein InteractionsLigand BindingMacromolecular AssemblyMultivalent InteractionsVirus-like NanoparticlesGlycan-mediated BindingGlycan-receptor InteractionsGlycoprotein StructureHost-pathogen Glycan InteractionsMultivalency In Glycan BindingPathogen-host InteractionsSurface AreaViral Glycoproteins
Ligand polyvalency is a powerful modulator of protein–receptor interactions. Host–pathogen infection interactions are often mediated by glycan ligand–protein interactions, yet its interrogation with very high copy number ligands has been limited to heterogenous systems. Here we report that through the use of nested layers of multivalency we are able to assemble the most highly valent glycodendrimeric constructs yet seen (bearing up to 1,620 glycans). These constructs are pure and well-defined single entities that at diameters of up to 32 nm are capable of mimicking pathogens both in size and in their highly glycosylated surfaces. Through this mimicry these glyco-dendri-protein-nano-particles are capable of blocking (at picomolar concentrations) a model of the infection of T-lymphocytes and human dendritic cells by Ebola virus. The high associated polyvalency effects (β>106, β/N ~102–103) displayed on an unprecedented surface area by precise clusters suggest a general strategy for modulation of such interactions. Host–pathogen relationships can be mediated by polyvalent glycan ligand–protein interactions. Here well-defined highly valent glycodendrimeric constructs are synthesized that can mimic pathogens, and can inhibit a model of infection by the Ebola virus.
47
Christian W. Tornøe, Caspar Christensen, Morten Meldal · The Journal of Organic Chemistry · 2002 · 8.5K citations